Boyd Biomedical

The potential for accurate, affordable, and accessible diagnostic tests is enormous. Test more people, more often, prevent or diagnose, change the prevalence of disease. It’s that simple and this is how Sherlock Biosciences plans to bend the curve on population health.

Is the transition from volume-based to value-based care good or bad for innovation? - Value-based care models, if not well-structured, can potentially limit patient choice and impede access to innovative treatments by promoting a one-size-fits-all approach to healthcare. This heads in the opposite direction of patient centric personalized care. - The shift to value-based care necessitates innovations in healthcare, requiring a focus on outcomes and patient-led solutions versus technology-led solutions. This drives us towards more real world evidence and patient engagement. New technologies are enabling more patient-centric solutions but can they survive the path to commercialization? We talk about this with Access Vascular, Inc. CEO Jim Biggins.

Solve complexity with simplicity. Lisa Anderson, CEO of Paragonix Technologies, Inc. elaborates, Every procedure is a logistical masterpiece – everything has to work. Teams that have never met before have to collaborate. We knew we could not overcomplicate this and that we had to provide a simple solution. Our products are very intuitive. They have 6 simple steps to put together and take apart. And you can do it at three o’clock in the morning when the majority of transplantations take place.

Our mission is – to provide the industry-leading growth platform to biomedical innovators commercializing breakthrough devices. We do this by bringing together the essential commercialization skillsets - the technique of designing, the craft of producing, and the art of marketing. We help you bring your biomedical innovation best to market.

Check out our walk and talk tour with the team at Access Vascular, Inc. Access Vascular is solving the greatest challenges in vascular access with a midline catheter and peripherally inserted central catheter.

Our documentary film, Project Frontline, is available for viewing online now. Project Frontline is a feature length documentary film which tells the inspiring story of collaboration during crisis and a cautionary tale about our leadership in innovation, advanced manufacturing, and supply chain resilience. Check out our documentary film now - watch the full feature here: https://bit.ly/442bMjf

This is a show about biomedical innovation. We interview organizations to meet people and learn how they design, build and launch novel medical devices and therapies. What does it look like? How are they doing it? What can we learn from them?

How are you adjusting to the pace of technological advancement? Captive operations can't keep up with the rate of technological change today. Improvements to scale and efficiency won't solve the problem. The capacity to be agile - to continuously deliver new products in a state of near constant change - is enhanced by enabling partners in your network. This is networked adaptability. This is the gap that needs closing.

Think about all the innovation that has gone into treating patients with end stage organ failure and caring for transplant patients after they receive a transplant. Yet, the hours where the organ is outside of a body were forgotten. Paragonix Technologies, Inc. has taken an elegant simple solution and brought it to the market to drive a standard of care change. Now they are building real world data to support these improvements.

What is high quality? Quality means luxury. Quality means meeting spec. Quality means creative magic. Yes…to all three. This is what “best to market” means to us. This is why we are an end-to-end design and development firm. This is why we’ve been manufacturing in Massachusetts for 44 years. This is why we are a full-service marketing agency. Design. Build. Launch. Best to market.